Sweden’s market for In-Vitro Diagnostics is currently estimated to be worth USD 59.57 billion in the year 2014 and is expected to reach USD 81 billion by the end of 2020. The CAGR during this period of the forecast is 5.25%.
Currently, North America dominates the global market, with the market yet to reach saturation. Europe is the second-largest market in the world for In-Vitro Diagnostics and is expected to continue this domination to a certain extent. This escalation is developing the need to analyze, review and forecast the growth of the In-Vitro Diagnostics market.
Sweden In-Vitro Diagnostics Market-Market Dynamics
The report details several factors driving and restraining the growth of the market. Some of these are discussed below.
Some of the factors contributing to the growth of market are:
Some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.
The report studies in detail the market for different In-Vitro Diagnostic techniques, which include clinical chemistry, hematology, immunoassays, point of care diagnostics, molecular diagnostics and coagulation. The products sector includes instruments, reagents, and data management systems. Molecular diagnostics currently dominate the global market and are expected to dominate it in the near future also.
What the Report Offers
Looking to Customize Report?